Optipharm.CO.LTD Net Asset Quality Index
Optipharm.CO.LTD net asset quality index. Optipharm.CO.LTD (153710) has a Net Asset Quality Index of 61.4% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩39.96 Billion minus total liabilities of ₩15.42 Billion yields net assets of ₩24.55 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Optipharm.CO.LTD for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Optipharm.CO.LTD (2015–2025)
Net asset quality index of Optipharm.CO.LTD from 2015 to 2025. This chart shows how Optipharm.CO.LTD's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the index stands at 61.4%, representing net assets of ₩24.55 Billion against total assets of ₩39.96 Billion KRW. Check 153710 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Optipharm.CO.LTD Net Asset Quality Index by Year (2015–2025)
Optipharm.CO.LTD net asset quality index by year from 2015 to 2025. The table below presents the year-by-year Net Asset Quality Index for Optipharm.CO.LTD from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 153710 stock market capitalisation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.3% | ₩25.40 Billion | ₩40.77 Billion | ₩15.37 Billion | ▼ -0.8 pp |
| 2024 | 63.1% | ₩27.34 Billion | ₩43.32 Billion | ₩15.98 Billion | ▼ -0.9 pp |
| 2023 | 64.0% | ₩25.14 Billion | ₩39.28 Billion | ₩14.13 Billion | ▼ -6.4 pp |
| 2022 | 70.4% | ₩29.01 Billion | ₩41.18 Billion | ₩12.17 Billion | ▼ -4.7 pp |
| 2021 | 75.2% | ₩30.96 Billion | ₩41.17 Billion | ₩10.21 Billion | ▼ -6.6 pp |
| 2020 | 81.7% | ₩33.78 Billion | ₩41.32 Billion | ₩7.54 Billion | ▼ -3.6 pp |
| 2019 | 85.4% | ₩35.61 Billion | ₩41.72 Billion | ₩6.11 Billion | ▲ +2.2 pp |
| 2018 | 83.1% | ₩35.44 Billion | ₩42.64 Billion | ₩7.20 Billion | ▲ +18.7 pp |
| 2017 | 64.4% | ₩12.79 Billion | ₩19.84 Billion | ₩7.06 Billion | ▼ -1.2 pp |
| 2016 | 65.6% | ₩13.50 Billion | ₩20.58 Billion | ₩7.08 Billion | ▲ +40.9 pp |
| 2015 | 24.7% | ₩4.30 Billion | ₩17.41 Billion | ₩13.12 Billion | — |